Access to a Saxitoxin-like Library for Binding Studies of Na Voltage Channels
访问类石房蛤毒素库进行 Na 电压通道的结合研究
基本信息
- 批准号:9049411
- 负责人:
- 金额:$ 5.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-01 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnalgesicsArchitectureBindingBiologyChemicalsChemistryCommunitiesComplexCyclizationDataDevelopmentDrug DesignFutureGenerationsGuanidinesHealthHumanIn SituIntegral Membrane ProteinIon ChannelLibrariesLinkMammalsMetalsMethodsMolecular ProbesNeurotoxinsPainPain managementPatternPlayPopulationPropertyProteinsResearchRoleRouteSaxitoxinSodiumStructureStructure-Activity RelationshipTherapeuticTransition Elementschronic paindesigndiazo compounddrug developmentguanidiniumimprovedinterestneurotoxicpropadienepublic health relevancescaffoldsmall moleculesmall molecule librariestoolvoltage
项目摘要
DESCRIPTION (provided by applicant): Development of a Lewis acidic transition-metal promoted cyclization of a bis-guanidinium allenyl unit leading toward tricyclic cores resembling saxitoxin will be undertaken. This will probe the reactivity profile of an otherwise unknown bis-guanidinium substituted allene insofar as its reactivity towards cyclizations is concerned. A modular approach is presented that allows for access to various substitution patterns and ring-sizes closely resembling saxitoxin for further structure-activity relationship (SAR) studies agains human sodium voltage (NaV) channels. Subtypes of these NaV channels have been linked to the mechanism of pain, which has sparked heavy interest in analgesic drug development. The lack of crystal structure data for the transmembrane proteins, however, hinders rational drug design. Such SAR studies with unnatural derivatives of saxitoxin against these channels are extremely limited or unknown and would help to elucidate the architecture of these proteins for future therapeutics. Current estimates conclude that ~30% of the U.S. population is afflicted with chronic pain; therefore, further understanding of these transmembrane proteins is paramount. Completion of the proposed research will achieve the following: 1) A better understanding of the reactivity profile in C−N bond construction of an allene unit using guanidine as nucleophiles; 2)
Access to a metal carbenoid species in situ which has broad synthetic utility in the chemistry community, an alternative route that avoids potentially explosive diazo compounds; 3) Potential platform to access bis-guanidinium tricyclic cores with various ring-sizes and substitution patterns; 4) Correlate structure-activity relationships of saxitoxin-like scaffolds against the human NaV1.7 ion channel aiding in their structural elucidation for future rational design in analgesics of therapeutic value.
描述(由申请人提供):将进行路易斯酸性过渡金属促进的双胍基烯丙基单元的环化反应,该环化单元通向类似萨克托毒素的三环核心。这将探索一种未知的双胍取代的烯丙烯的反应性,因为它对环化反应的活性是有关的。提出了一种模块化的方法,允许访问各种替换模式和环大小非常类似于岩藻毒素,以进一步研究结构-活性关系(SAR)与人的钠电压(NAV)通道。这些NAV通道的亚型与疼痛的机制有关,这引发了人们对止痛药开发的浓厚兴趣。然而,缺乏跨膜蛋白的晶体结构数据阻碍了合理的药物设计。使用非天然的肉毒素衍生物对这些通道进行的SAR研究非常有限或未知,这将有助于阐明这些蛋白质的结构,用于未来的治疗。目前的估计是,大约30%的美国人口受到慢性疼痛的困扰;因此,对这些跨膜蛋白的进一步了解至关重要。拟议研究的完成将实现以下成果:1)更好地了解使用胍作为亲核剂的联烯单元的C−N键结构中的反应性分布;2)
获得在化学界具有广泛合成用途的金属类卡宾物种,这是避免潜在爆炸性重氮化合物的另一种途径;3)获得具有不同环大小和取代模式的双鸟苷三环核心的潜在平台;4)关联类萨曲霉毒素支架与人类Nav1.7离子通道的结构-活性关系,为未来具有治疗价值的止痛药的合理设计提供帮助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas A. Isley其他文献
C—C Bond Formation via Copper‐Catalyzed Conjugate Addition Reactions to Enones in Water at Room Temperature.
室温下,通过铜催化的水中烯酮的共轭加成反应形成 C—C 键。
- DOI:
10.1002/chin.201322040 - 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
B. Lipshutz;Shenlin Huang;W. W. Y. Leong;Guofu Zhong;Nicholas A. Isley - 通讯作者:
Nicholas A. Isley
Cover Picture: On the Way Towards Greener Transition‐Metal‐Catalyzed Processes as Quantified by E Factors (Angew. Chem. Int. Ed. 42/2013)
封面图片:通过 E 因子量化迈向更绿色的过渡金属催化过程(Angew. Chem. Int. Ed. 42/2013)
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
B. Lipshutz;Nicholas A. Isley;J. Fennewald;E. Slack - 通讯作者:
E. Slack
Transforming Suzuki—Miyaura Cross‐Couplings of MIDA Boronates into a Green Technology: No Organic Solvents.
将 MIDA 硼酸酯的 Suzuki-Miyaura 交叉偶联转化为绿色技术:无有机溶剂。
- DOI:
10.1002/chin.201427086 - 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Nicholas A. Isley;F. Gallou;B. Lipshutz - 通讯作者:
B. Lipshutz
Switching from organic solvents to water at an industrial scale
在工业规模上从有机溶剂转向水
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
M. Parmentier;Christopher M. Gabriel;Pengfei Guo;Nicholas A. Isley;Jianguang Zhou;F. Gallou - 通讯作者:
F. Gallou
Nicholas A. Isley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas A. Isley', 18)}}的其他基金
Access to a Saxitoxin-like Library for Binding Studies of Na Voltage Channels
访问类石房蛤毒素库进行 Na 电压通道的结合研究
- 批准号:
9215525 - 财政年份:2016
- 资助金额:
$ 5.25万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 5.25万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 5.25万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 5.25万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 5.25万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 5.25万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 5.25万 - 项目类别: